DIFLUCAN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug DIFLUCAN contains one active pharmaceutical ingredient (API):

1	Fluconazole UNII 8VZV102JFY - FLUCONAZOLE
	Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.
	Read more about Fluconazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DIFLUCAN Solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
DIFLUCAN Hard capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
DIFLUCAN Tablet / Oral suspension	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC01	Fluconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1471K, 1472L, 1475P, 5446P
CA	Health Products and Food Branch	00891835, 02024152, 02141442
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00766564, 00766570, 03577817, 03577823, 03720255, 03720261, 04893029, 04893035, 06331057, 08605754, 08605760
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4373-MEE-0918
EE	Ravimiamet	1007109, 1007187, 1558133, 1558144, 1558155, 1558166, 1558177, 1558188, 1558199, 1558201, 1558212, 1558223, 1558234, 1558245, 1558256, 1558267, 1558278, 1558289, 1560103, 1560114, 1591589, 1591590, 1591602, 1591613, 1591624, 1591635
ES	Centro de información online de medicamentos de la AEMPS	58765, 58766, 58803, 58804, 59672, 59673
FI	Lääkealan turvallisuus- ja kehittämiskeskus	159979, 399105, 409250, 446807, 446930, 566992
GB	Medicines & Healthcare Products Regulatory Agency	143179, 180561, 180563, 185744, 195425, 200345, 20972, 20973, 23848, 23856, 23861
HK	Department of Health Drug Office	31174, 31175, 32536, 38313
HR	Agencija za lijekove i medicinske proizvode	HR-H-503344712, HR-H-595109192, HR-H-705762545, HR-H-744744897
IE	Health Products Regulatory Authority	21172, 21180, 21296, 21326, 90328, 90336
IL	מִשְׂרַד הַבְּרִיאוּת	3624
IT	Agenzia del Farmaco	027267020, 027267044, 027267095, 045623016
JP	医薬品医療機器総合機構	6290002M1020, 6290002M2026, 6290002R1027, 6290002R2023, 6290401A1099, 6290401A2168, 6290401A3164
LT	Valstybinė vaistų kontrolės tarnyba	1008951, 1008952, 1008953, 1019863, 1068641, 1068642, 1068643, 1068644, 1068645, 1068646, 1068647, 1068648, 1068649, 1068650, 1068651, 1068652, 1068653, 1068654, 1068655, 1068656, 1068657, 1068658, 1068659, 1068660, 1068661, 1068662, 1068663, 1068664, 1068665, 1068666, 1068667, 1068668, 1068669, 1068670, 1068671, 1068672, 1068673, 1068674, 1068675, 1068676, 1068677, 1068678, 1068679, 1068680, 1068681, 1068682, 1068683, 1068684, 1068685, 1068686, 1068687, 1080431, 1082387
MT	Medicines Authority	AA565/68801
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	254M89, 518M89
NG	Registered Drug Product Database	04-1426
Switch country to Nigeria in order to find specific presentations of DIFLUCAN
NL	Z-Index G-Standaard	13784498, 13784501
NL	Z-Index G-Standaard, PRK	38237, 38245
NZ	Medicines and Medical Devices Safety Authority	11663, 5329, 5331, 5333, 5334, 8702, 8748, 8749
PL	Rejestru Produktów Leczniczych	100018876
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65084001, W65084002, W65084003, W65084004, W65084005, W65084006, W65084007, W65084008, W65084009, W65084010, W65084011, W65084012, W65084013, W65084014, W65084015, W65084016, W65084017, W65084018, W65084019, W65084020, W65084021, W65084022, W65084023, W65084024, W65084025, W65084026, W65084027, W65084028, W65084029, W65084030, W65084031, W65084032, W65084033, W65084034, W65085001, W65085002, W65085003, W65085004, W65085005, W65085006, W65085007, W65085008, W65085009, W65085010, W65085011, W65085012, W65085013, W65085014, W65085015, W65085016, W65085017, W65085018, W65085019, W65085020, W65085021, W65085022, W65085023, W65085024, W65085025, W65085026, W65085027, W65085028, W65085029, W65085030, W65085031, W65085032, W65085033, W65085034, W65086001, W65086002, W65086003, W65086004, W65086005, W65086006, W65086007, W65086008, W65086009, W65086010, W65086011, W65086012, W65087001, W65087002, W65087003, W65087004
SG	Health Sciences Authority	04457P, 04460P, 05770P, 06804P, 08903P, 08904P
TN	Direction de la Pharmacie et du Médicament	9243091
US	FDA, National Drug Code	0049-3410, 0049-3420, 0049-3430, 0049-3440, 0049-3450, 0049-3500, 55289-148
ZA	Health Products Regulatory Authority	28/20.2.2/0150, 28/20.2.2/0151, 30/20.2.2/0150, 30/20.2.2/0151, 35/20.2.2/0187, V/20.2.2/339, V/20.2.2/340, Z/20.2.2/271, Z/20.2.2/272